While more human studies are needed, curcumin supplements show potential as a natural aid for supporting appetite and glucose regulation. 2
Currently, Madrigal Pharmaceuticals Rezdiffra, approved in 2024, is the only other FDA-cleared treatment for MASH, as reported by Reuters
beta arrestin recruitment to the GIP receptor is a key regulator of receptor signaling, particularly in post-activation trafficking, including receptor internalization, continued signaling from intracellular compartments like endosomes and recycling of the receptor back to the cell surface
Chem Res Toxicol 12:809815
Many experts argue it is not
A medical consultation is needed to determine whether treatment is appropriate for you